MYLAN 211 (Amitriptyline and chlordiazepoxide 12.5 mg / 5 mg)
Pill imprint MYLAN 211 has been identified as Amitriptyline and chlordiazepoxide 12.5 mg / 5 mg.
Amitriptyline/chlordiazepoxide is used in the treatment of anxiety; depression and belongs to the drug class psychotherapeutic combinations. FDA has not classified the drug for risk during pregnancy. Amitriptyline/chlordiazepoxide 12.5 mg / 5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- MYLAN 211
- 12.5 mg / 5 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Psychotherapeutic combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about amitriptyline/chlordiazepoxide
- Side Effects
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 8 Reviews – Add your own review/rating
- Drug class: psychotherapeutic combinations
- Amitriptyline and chlordiazepoxide
- Chlordiazepoxide and amitriptyline (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.